Yipinhong Pharmaceutical Co Ltd
SZSE:300723
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
Price:
22.74 CNY
2.25%
Market Closed
Updated:
May 3, 2024
Yipinhong Pharmaceutical Co Ltd
Net Income (Common)
|
Yipinhong Pharmaceutical Co Ltd
Net Income (Common) Peer Comparison
Comparables:
H
3692
600436
600276
000538
C
300765
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Yipinhong Pharmaceutical Co Ltd
SZSE:300723
|
Net Income (Common)
¥306.7m
|
CAGR 3-Years
21%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Net Income (Common)
¥3.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Net Income (Common)
¥2.8B
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Net Income (Common)
¥4.2B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Net Income (Common)
¥4.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Net Income (Common)
¥755.6m
|
CAGR 3-Years
36%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
See Also
What is Yipinhong Pharmaceutical Co Ltd's Net Income (Common)?
Net Income (Common)
306.7m
CNY
306.7m
CNY
Based on the financial report for Sep 30, 2023, Yipinhong Pharmaceutical Co Ltd's Net Income (Common) amounts to 306.7m CNY.
What is Yipinhong Pharmaceutical Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
11%
11%
Over the last year, the Net Income (Common) growth was 8%. The average annual Net Income (Common) growth rates for Yipinhong Pharmaceutical Co Ltd have been 21% over the past three years , 11% over the past five years .
You don't have any saved screeners yet
